Shareholding for the Period Ended September 30, 2016
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here10-10-2016
10-10-2016
Closure of Trading Window
Chemo Pharma Laboratories Ltd has informed BSE that as per the Company's Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading] Regulations, 1992, the Trading Window for dealing in the securities of the Company will be closed for the purpose of declaration of Audited Financial Results of the Company for the Quarter ended September 30, 2016 for all the Officers...07-10-2016
Board Meeting Intimation for Results
Chemo Pharma Laboratories Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on October 24, 2016, inter alia, to transact the following business:1. To consider and approve the Un-Audited Financial Results for the quarter ended September 30, 2016.2. To place and take on record the Limited Review Report on Un-Audited Financial Results for the quarter ended September 30, 2016.07-10-2016
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Chemo Pharma Laboratories Ltd has informed BSE regarding the details of Voting results at the 74th Annual General Meeting (AGM) of the Company held on August 30, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report.01-09-2016
Outcome of AGM
Chemo Pharma Laboratories Ltd has submitted to BSE a copy of proceedings of 74th Annual General Meeting (AGM) of the Company held on August 30, 2016.31-08-2016
Standalone Financial Results, Limited Review Report for June 30, 2016
Chemo Pharma Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 201622-07-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Chemo Pharma Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.21-07-2016
Shareholding for the Period Ended June 30, 2016
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here20-07-2016
Closure of Trading Window
Chemo Pharma Laboratories Ltd has informed BSE that as per the Companys Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the securities of the Company will be closed for the purpose of declaration of Audited Financial Results of the Company for the Quarter ended June 30, 2016 for all the Officers...08-07-2016
Board Meeting Intimation for Results
Chemo Pharma Laboratories Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on July 22, 2016, to transact the following business:1. To consider and approve the Un-Audited Financial Results for the quarter ended June 30, 2016.2. To place and take on record the Limited Review Report on Un-Audited Financial Results for the quarter ended June 30, 2016.08-07-2016